1. Home
  2. KALA vs IZM Comparison

KALA vs IZM Comparison

Compare KALA & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • IZM
  • Stock Information
  • Founded
  • KALA 2009
  • IZM 2011
  • Country
  • KALA United States
  • IZM China
  • Employees
  • KALA N/A
  • IZM N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • KALA Health Care
  • IZM Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • IZM Nasdaq
  • Market Cap
  • KALA 26.2M
  • IZM 31.8M
  • IPO Year
  • KALA 2017
  • IZM 2023
  • Fundamental
  • Price
  • KALA $5.97
  • IZM $2.51
  • Analyst Decision
  • KALA Strong Buy
  • IZM
  • Analyst Count
  • KALA 3
  • IZM 0
  • Target Price
  • KALA $14.00
  • IZM N/A
  • AVG Volume (30 Days)
  • KALA 135.3K
  • IZM 31.8K
  • Earning Date
  • KALA 08-05-2025
  • IZM 07-29-2025
  • Dividend Yield
  • KALA N/A
  • IZM N/A
  • EPS Growth
  • KALA N/A
  • IZM N/A
  • EPS
  • KALA N/A
  • IZM N/A
  • Revenue
  • KALA N/A
  • IZM $180,553,977.00
  • Revenue This Year
  • KALA N/A
  • IZM N/A
  • Revenue Next Year
  • KALA N/A
  • IZM N/A
  • P/E Ratio
  • KALA N/A
  • IZM N/A
  • Revenue Growth
  • KALA N/A
  • IZM N/A
  • 52 Week Low
  • KALA $2.92
  • IZM $1.18
  • 52 Week High
  • KALA $11.20
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • KALA 60.41
  • IZM 50.31
  • Support Level
  • KALA $5.39
  • IZM $2.50
  • Resistance Level
  • KALA $6.30
  • IZM $2.65
  • Average True Range (ATR)
  • KALA 0.70
  • IZM 0.10
  • MACD
  • KALA 0.05
  • IZM -0.02
  • Stochastic Oscillator
  • KALA 60.98
  • IZM 32.35

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: